Selling And Administration Expenses Изменить Дата
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Acorda Therapeutics USD 21.82M 689K 2023-06
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Akebia Therapeutics USD 25.44M 2.73M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Bluebird Bio USD 40.7M 354K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Enanta Pharmaceuticals USD 13.8M 1.18M 2023-09
Esperion Therapeutics USD 33.24M 719K 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Heron Therapeutics USD 24.6M 11.84M 2023-09
Insmed USD 89.53M 1.1M 2023-12
J&J USD 5.81B 410M 2023-12
Lexicon Pharmaceuticals USD 32.23M 2.22M 2023-09
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
Merck USD 2.75B 272M 2023-12
Minerva Neurosciences USD 2.64M 3.06K 2023-09
Moderna USD 470M 28M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
PTC Therapeutics USD 76.29M 4.6M 2023-12
Takeda JPY 252.95B 4.84B 2023-09
Teva Pharmaceutical Industries USD 844M 66M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vanda Pharmaceuticals USD 28.4M 7.7M 2023-06
Veracyte USD 49.06M 9.55M 2023-12



Vanda Pharmaceuticals Коммерческие И Административные Расходы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.